Physician
Mante Pediatrics LLC
Mante Pediatrics LLC was paid $7.00M by Medicaid between Jan 2018 and Dec 2024, across 59 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoMANTE PEDIATRICS LLC
LANCASTER, SC 29720
LANCASTER, SC 29720
33aNPI1508063371assigned 06/27/2007
33bProvider typePediatrics Physician
28Total paid$7.00M
24GClaims139,817
24DCodes billed59
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in South Carolina
Rank by total paid#20 of 471
Median peer was paid$18K
This provider vs. median397×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,475 | $808K | |
| 2019 | 21,179 | $927K | |
| 2020 | 16,978 | $836K | |
| 2021 | 21,272 | $1.08M | |
| 2022 | 22,165 | $1.18M | |
| 2023 | 21,747 | $1.19M | |
| 2024incomplete | 17,001 | $984K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 25,161 | 22,256 | $2.50M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 23,625 | 20,116 | $1.62M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6.2% | 8,690 | 7,578 | $434K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.8% | 8,888 | 8,436 | $407K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.6% | 3,201 | 3,124 | $319K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.3% | 3,317 | 2,869 | $300K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.7% | 2,346 | 2,195 | $256K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.3% | 2,277 | 2,152 | $228K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.0% | 4,907 | 4,682 | $139K |
| 90461 | 1.8% | 3,552 | 3,427 | $123K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 8,287 | 7,688 | $119K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.1% | 536 | 490 | $76K |
47 more codes
| 97802 | 1.1% | 3,076 | $76K | |
| 99051 | <1% | 4,264 | $50K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,841 | $41K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 980 | $38K |
| G9153 | Mapcp demonstration - physician incentive pool | <1% | 826 | $33K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 4,646 | $33K |
| 99381 | <1% | 300 | $31K | |
| 97803 | <1% | 1,583 | $29K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 588 | $29K |
| 96127 | <1% | 3,921 | $27K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,040 | $24K |
| 87807 | <1% | 1,359 | $16K | |
| 81002 | <1% | 4,086 | $12K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 77 | $11K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 54 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,890 | $7K |
| 81025 | <1% | 637 | $4K | |
| 99401 | <1% | 142 | $4K | |
| 99383 | <1% | 28 | $3K | |
| 99384 | <1% | 14 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 598 | $1K |
| 69210 | <1% | 43 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 13 | $1K |
| G9762 | Patient had at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays | <1% | 13 | $450.00 |
| 80305 | <1% | 15 | $137.62 | |
| 94760 | <1% | 150 | $69.37 | |
| 90651 | 0% | 913 | $0.00 | |
| 90696 | 0% | 247 | $0.00 | |
| 90744 | 0% | 364 | $0.00 | |
| 90680 | 0% | 161 | $0.00 | |
| 90698 | 0% | 504 | $0.00 | |
| 90647 | 0% | 659 | $0.00 | |
| 90723 | 0% | 168 | $0.00 | |
| 90686 | 0% | 140 | $0.00 | |
| 90697 | 0% | 81 | $0.00 | |
| 99000 | 0% | 44 | $0.00 | |
| 90670 | 0% | 2,077 | $0.00 | |
| 90734 | 0% | 925 | $0.00 | |
| 90715 | 0% | 637 | $0.00 | |
| 90700 | 0% | 442 | $0.00 | |
| 90633 | 0% | 1,994 | $0.00 | |
| 90681 | 0% | 392 | $0.00 | |
| 90710 | 0% | 1,084 | $0.00 | |
| 90649 | 0% | 423 | $0.00 | |
| 90658 | 0% | 560 | $0.00 | |
| 90713 | 0% | 12 | $0.00 | |
| 90672 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMANTE, EBENEZER (OWNER)